The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “TheValensCompany” or “Valens”), a leading manufacturer of cannabis products, today launched two new flavours of the top-selling Summit 10 beverage in partnership with A1 Cannabis Company (“A1 Cannabis” or “A1“). Summit 10 Raspberry Lemonade and Summit 10 Peach Lemonade will be available as part of the Summit product lineup of THC-forward beverages and edibles.
Summit 10 Raspberry Lemonade and Summit 10 Peach Lemonade are refreshing 10mg THC beverages made with concentrated raspberry juice and natural white peach flavour respectively. Both drinks are non-carbonated and come in bottles with resealable lids, allowing for controlled consumption as desired. Summit 10 was developed using SōRSE by Valens emulsion technology and is designed for consumers seeking a higher dosage product with faster-observed onset times and reduced offset times. The two new flavours will first be available in British Columbia, with their introduction into the Alberta market to follow later this summer.
The Summit cannabis-infused beverage offerings have received positive reviews in Canada for their differentiated taste and customizable dosing from the industry and consumers alike. In addition to the new beverage flavours, the following products are currently available as part of the Summit lineup from A1 Cannabis:
- Summit 10 THC Lemonade Iced Tea (10mg THC) available in Alberta, British Columbia, Ontario, Manitoba, Saskatchewan, and Yukon, and ranked among the top three cannabis-infused beverage SKUs in participating Canadian markets, for the period May 1, 2021, to July 31, 2021*
- Summit Wild Berry Soft Chews (2 x 5mg THC) available in Alberta and Ontario
Basecamp CBD-only Iced Tea (15mg CBD), formulated using SōRSE by Valens technology, is also available from Valens and A1 in Alberta, British Columbia, Ontario, Saskatchewan, and Yukon. Valens will continue to produce and distribute cannabis-infused beverages out of its Kelowna campus with the intention to move beverage manufacturing to its facility in the Greater Toronto Area upon receipt of its Health Canada licence.
At Valens, It’s Personal.
*Based on Hifyre data for Alberta, British Columbia, Ontario, and Saskatchewan
